Key Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.1K Hold
7
– – ﹤0.01% 670
2026
Q2
$1.11K Hold
7
– – ﹤0.01% 647
2026
Q1
$894 Buy
+7
New +$874 ﹤0.01% 612

Other funds holding XBI

Key Capital Management's XBI Position: Q3 2026 in Review

Key Capital Management held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 7 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Key Capital Management first reported a position in XBI in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.11K in Q2 2026. 963 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Key Capital Management held 7 shares of State Street SPDR S&P Biotech ETF worth $1.1K as of Q3 2026.
  • Key Capital Management left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Key Capital Management's portfolio in Q3 2026, its #670 holding.
  • Key Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 3 quarters since.
  • Key Capital Management's State Street SPDR S&P Biotech ETF position peaked at $1.11K in Q2 2026.
  • 963 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Key Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.